NEOFOX STUDY UPDATE WITH REGARDS TO COVID-19
Malmö, Sweden, 3 December 2020 – WntResearch AB (publ) (Spotlight: WNT), announces that the escalating development of Covid-19 continues to affect the conduct of the NEOFOX study. As a result, activities related to the study will be kept to a minimum over the next 6 months, primarily to ensure the safety of patients, healthcare professionals, staff and providers involved in the study.Additional guidelines and restrictions in Hungary and Spain, where the Neofox study is ongoing, and in the Netherlands, where the responsible CRO[1] CATO SMS is based, have been introduced to